W. Frankle, J. Lerma, and M. Laruelle, The Synaptic Hypothesis of Schizophrenia, Neuron, vol.39, issue.2, pp.205-216, 2003.
DOI : 10.1016/S0896-6273(03)00423-9

K. Franklin, G. Paxinos, M. Galiano, C. Bosc, A. Schweitzer et al., The Mouse Brain in Stereotaxic Coordinates Academic Press Astrocytes and oligodendrocytes express different STOP protein isoforms, J Neurosci Res, vol.78, pp.329-337, 1997.

G. Geraud, A. -. Bes, M. Guell, A. Bes, and A. , Reversibility of Hemodynamic Hypofrontality in Schizophrenia, Journal of Cerebral Blood Flow & Metabolism, vol.5, issue.1, pp.9-12, 1987.
DOI : 10.1038/jcbfm.1987.2

N. Ginovart, L. Farde, C. Halldin, and C. Swahn, Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with pet in nonhuman primates, Synapse, vol.234, issue.2, pp.154-162, 1999.
DOI : 10.1002/(SICI)1098-2396(199902)31:2<154::AID-SYN9>3.0.CO;2-K

D. Goff and J. Coyle, The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia, American Journal of Psychiatry, vol.158, issue.9, pp.1367-1377, 2001.
DOI : 10.1176/appi.ajp.158.9.1367

S. Gory-faure, V. Windscheid, C. Bosc, L. Peris, D. Proietto et al., STOP-like Protein 21 Is a Novel Member of the STOP Family, Revealing a Golgi Localization of STOP Proteins, Journal of Biological Chemistry, vol.281, issue.38, pp.28387-28396, 2006.
DOI : 10.1074/jbc.M603380200

URL : https://hal.archives-ouvertes.fr/inserm-00380095

A. Grace, Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia, Neuroscience, vol.41, issue.1, pp.1-24, 1991.
DOI : 10.1016/0306-4522(91)90196-U

L. Guillaud, C. Bosc, A. Fourest-lieuvin, E. Denarier, F. Pirollet et al., STOP Proteins are Responsible for the High Degree of Microtubule Stabilization Observed in Neuronal Cells, The Journal of Cell Biology, vol.15, issue.1, pp.167-179, 1998.
DOI : 10.1083/jcb.133.1.151

A. Guyton, Anatomie et Physiologie du Syst me Nerveux Central è . D carie/Vigot é, 1989.

A. Horton and M. Ehlers, Secretory trafficking in neuronal dendrites, Nature Cell Biology, vol.14, issue.7, pp.585-591, 2004.
DOI : 10.1038/nrn785

D. Hubl, T. Koenig, W. Strik, A. Federspiel, R. Kreis et al., Pathways That Make Voices, Archives of General Psychiatry, vol.61, issue.7, pp.658-668, 2004.
DOI : 10.1001/archpsyc.61.7.658

J. Hudry, M. Saoud, D. Amato-'t, J. Dal-ry-É, and J. Royet, Ratings of Different Olfactory Judgements in Schizophrenia, Chemical Senses, vol.27, issue.5, pp.407-416, 2002.
DOI : 10.1093/chemse/27.5.407

T. Jay, M. Jouvet, and M. Des-rosiers, Local cerebral glucose utilization in the free moving mouse: a comparison during two stages of the activity-rest cycle, Brain Research, vol.342, issue.2, pp.297-306, 1985.
DOI : 10.1016/0006-8993(85)91129-1

R. Kaplan, H. Szechtman, S. Franco, B. Szechtman, C. Nahmias et al., Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by position emission tomography (PET), Schizophrenia Research, vol.11, issue.1, pp.47-54, 1993.
DOI : 10.1016/0920-9964(93)90037-J

S. Kapur and R. G. , Serotonin-dopamine interaction and its relevance to schizophrenia, Am J Psychiatry, vol.153, pp.466-476, 1996.

R. Kerwin, Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis1, Psychological Medicine, vol.22, issue.03, pp.547-551, 1993.
DOI : 10.1016/0024-3205(83)90797-X

A. Kolman, BMS-310705 Bristol-Myers Squibb/GBF, Curr Opin Investig Drugs, vol.5, pp.1292-1297, 2004.

L. Kopala, K. Good, K. Morrison, A. Bassett, A. M. Honer et al., Impaired Olfactory Identification in Relatives of Patients With Familial Schizophrenia, American Journal of Psychiatry, vol.158, issue.8, pp.1286-1290, 2001.
DOI : 10.1176/appi.ajp.158.8.1286

A. Lahti, H. Holcomb, M. Weiler, D. Medoff, K. Frey et al., Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex, Neuropsychopharmacology, vol.29, issue.1, pp.171-178, 2004.
DOI : 10.1038/sj.npp.1300312

A. Lahti, H. Holcomb, M. Weiler, D. Medoff, and C. Tamminga, Functional effects of antipsychotic drugs: comparing clozapine with haloperidol, Biological Psychiatry, vol.53, issue.7, pp.601-608, 2003.
DOI : 10.1016/S0006-3223(02)01602-5

A. Lahti, M. Weiler, H. Holcomb, C. Tamminga, W. Carpenter et al., Correlations Between rCBF and Symptoms in Two Independent Cohorts of Drug-Free Patients with Schizophrenia, Neuropsychopharmacology, vol.10, pp.221-230, 2006.
DOI : 10.1038/sj.npp.1300837

M. Laruelle, A. Abi-dargham, C. Van-dyck, R. Gil, D. Souza-'cd et al., Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects., Proceedings of the National Academy of Sciences, vol.93, issue.17, pp.9235-9240, 1996.
DOI : 10.1073/pnas.93.17.9235

P. Liddle, K. Friston, C. Frith, S. Hirsch, T. Jones et al., Patterns of cerebral blood flow in schizophrenia, The British Journal of Psychiatry, vol.160, issue.2, pp.179-186, 1992.
DOI : 10.1192/bjp.160.2.179

R. Margolis and L. Wilson, Opposite end assembly and disassembly of microtubules at steady state in vitro, Cell, vol.13, issue.1, pp.1-8, 1978.
DOI : 10.1016/0092-8674(78)90132-0

D. Mathalon, J. Ford, and A. Pfefferbaum, Trait and state aspects of p300 amplitude reduction in schizophrenia: a retrospective longitudinal study, Biological Psychiatry, vol.47, issue.5, pp.434-449, 2000.
DOI : 10.1016/S0006-3223(99)00277-2

R. Mccurdy, F. Feron, C. Perry, D. Chant, D. Mclean et al., Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses, Schizophrenia Research, vol.82, issue.2-3, pp.163-173, 2006.
DOI : 10.1016/j.schres.2005.10.012

S. Min, S. An, D. Jon, and J. Lee, Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study, Psychiatry Research: Neuroimaging, vol.90, issue.3, pp.159-68, 1999.
DOI : 10.1016/S0925-4927(99)00014-1

T. Mitchison and M. Kirschner, Dynamic instability of microtubule growth, Nature, vol.61, issue.5991, pp.237-242, 1984.
DOI : 10.1038/312237a0

P. Moberg, R. Agrin, R. Gur, R. Gur, B. Turetsky et al., Olfactory Dysfunction in Schizophrenia A Qualitative and Quantitative Review, Neuropsychopharmacology, vol.21, issue.3, pp.325-340, 1999.
DOI : 10.1016/S0893-133X(99)00019-6

J. Monti and D. Monti, Sleep in schizophrenia patients and the effects of antipsychotic drugs, Sleep Medicine Reviews, vol.8, issue.2, pp.133-148, 2004.
DOI : 10.1016/S1087-0792(02)00158-2

D. Murphy, N. Cole, V. Greenberger, and M. Segal, Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons, J Neurosci, vol.18, pp.2550-2559, 1998.

A. Nehlig, G. Lucignani, M. Kadekaro, L. Porrino, and L. Sokoloff, Effects of acute administration of caffeine on local cerebral glucose utilization in the rat, European Journal of Pharmacology, vol.101, issue.1-2, pp.91-100, 1984.
DOI : 10.1016/0014-2999(84)90034-7

A. Nehlig, L. Porrino, A. Crane, and L. Sokoloff, Local Cerebral Glucose Utilization in Normal Female Rats: Variations during the Estrous Cycle and Comparison with Males, Journal of Cerebral Blood Flow & Metabolism, vol.7, issue.3, pp.393-400, 1985.
DOI : 10.1111/j.1471-4159.1977.tb10649.x

R. Pazdur, A. Kudelka, J. Kavanagh, P. Cohen, and M. Raber, The taxoids: paclitaxel (Taxol??) and docetaxel (Taxotere??), Cancer Treatment Reviews, vol.19, issue.4, pp.351-86, 1993.
DOI : 10.1016/0305-7372(93)90010-O

L. Rioux, D. Ruscheinsky, and S. Arnold, Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia, Psychiatry Research, vol.128, issue.1, pp.1-7, 2004.
DOI : 10.1016/j.psychres.2004.05.022

C. Rupp, W. Fleischhacker, G. Kemmler, C. Kremser, R. Bilder et al., Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophrenia, Schizophrenia Research, vol.74, issue.2-3, pp.149-161, 2005.
DOI : 10.1016/j.schres.2004.07.010

O. Sabri, R. Erkwoh, M. Schreckenberger, U. Cremerius, G. Schulz et al., Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics, J Nucl Med, vol.38, pp.181-188, 1997.

M. Sallanon, K. Sakai, M. Denoyer, and M. Jouvet, Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat, Neuroscience, vol.32, issue.3, pp.669-683, 1989.
DOI : 10.1016/0306-4522(89)90289-3

H. Shimizu, Y. Iwayama, K. Yamada, T. Toyota, Y. Minabe et al., Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia, Schizophrenia Research, vol.84, issue.2-3, pp.244-252, 2006.
DOI : 10.1016/j.schres.2006.03.017

C. Siegel, M. Waldo, G. Mizner, L. Adler, and R. Freeman, Deficits in Sensory Gating in Schizophrenic Patients and Their Relatives, Archives of General Psychiatry, vol.41, issue.6, pp.607-612, 1984.
DOI : 10.1001/archpsyc.1984.01790170081009

R. Spitzer, M. Gibbon, A. Skodol, J. Williams, and M. First, DSM-IV Casebook American Psychiatry Press, Shinohara M, vol.14, 1977.

R. Szymusiak, N. Alam, T. Steininger, and D. Mcginty, Sleep???waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats, Brain Research, vol.803, issue.1-2, pp.178-188, 1998.
DOI : 10.1016/S0006-8993(98)00631-3

R. Szymusiak and E. Satinoff, Ambient temperature-dependence of sleep disturbances produced by basal forebrain damage in rats, Brain Research Bulletin, vol.12, issue.3, pp.295-305, 1984.
DOI : 10.1016/0361-9230(84)90057-1

S. Ticho and M. Radulovacki, Role of adenosine in sleep and temperature regulation in the preoptic area of rats, Pharmacology Biochemistry and Behavior, vol.40, issue.1, pp.33-40, 1991.
DOI : 10.1016/0091-3057(91)90317-U

T. Ugur, M. Weisbrod, E. Franzek, U. Pfuller, and H. Sauer, Olfactory impairment in monozygotic twins discordant for schizophrenia, European Archives of Psychiatry and Clinical Neuroscience, vol.160, issue.2, pp.94-98, 2005.
DOI : 10.1007/s00406-004-0536-8

D. Weinberger, K. Berman, and R. Zec, Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia, Archives of General Psychiatry, vol.43, issue.2, pp.114-124, 1986.
DOI : 10.1001/archpsyc.1986.01800020020004

A. Wolkin, M. Sanfilipo, A. Wolf, B. Angrist, J. Brodie et al., Negative Symptoms and Hypofrontality in Chronic Schizophrenia, Archives of General Psychiatry, vol.49, issue.12, pp.959-965, 1992.
DOI : 10.1001/archpsyc.1992.01820120047007

A. Wong, V. Tol, and H. , Schizophrenia: from phenomenology to neurobiology, Neuroscience & Biobehavioral Reviews, vol.27, issue.3, pp.269-306, 2003.
DOI : 10.1016/S0149-7634(03)00035-6

S. Yuasa, M. Kurachi, M. Suzuki, Y. Kadono, M. Matsui et al., Clinical symptoms and regional cerebral blood flow in schizophrenia, European Archives of Psychiatry and Clinical Neuroscience, vol.19, issue.1, pp.7-12, 1995.
DOI : 10.1007/BF02191809

K. Zakzanis and K. Hansen, Dopamine D2 densities and the schizophrenic brain, Schizophrenia Research, vol.32, issue.3, pp.201-206, 1998.
DOI : 10.1016/S0920-9964(98)00041-3